[fcb5af]: / literature / by_gene / FUBP1.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 34589661 10.1200/PO.21.00112 2022 Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II Glioma. FUBP1
2 35008187 10.3390/cancers14010023 2022 Low BACH2 Expression Predicts Adverse Outcome in Chronic Lymphocytic Leukaemia. FUBP1
3 35583604 10.1158/1078-0432.CCR-21-3347 2022 Interactome of Aiolos/Ikaros Reveals Combination Rationale of Cereblon Modulators with HDAC Inhibitors in DLBCL. FUBP1
4 36082445 10.1002/ijc.34278 2022 A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk. FUBP1
5 31467227 10.21873/cgp.20138 2020 Association of Leukemia Target Genes <i>Tet2, Bcl2</i>, and <i>Slc23a2</i> in Vitamin C Pathways. FUBP1
6 30500954 10.1093/nar/gky756 2019 Interplay between transcription regulators RUNX1 and FUBP1 activates an enhancer of the oncogene c-KIT and amplifies cell proliferation. FUBP1
7 27407063 10.1002/ijc.30263 2017 Mantle cell lymphoma-variant Richter syndrome: Detailed molecular-cytogenetic and backtracking analysis reveals slow evolution of a pre-MCL clone in parallel with CLL over several years. FUBP1
8 27599538 10.3892/mmr.2016.5718 2017 Expression of far upstream element binding protein 1 in B‑cell non‑Hodgkin lymphoma is correlated with tumor growth and cell‑adhesion mediated drug resistance. FUBP1